Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study

Overview of attention for article published in European Journal of Cancer (1965), August 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 3 news outlets
policy: 1 policy source

twitter: 58 X users
guideline: 1 clinical guideline source

Readers on

mendeley: 53 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

News story from British Medical Journal on Wednesday 22 January 2025

British Medical Journal, 22 Jan 2025

Oncology Drug Regulation Faces an Uncertain Future

OncLive, 01 Dec 2021

Maurie Markman, MD, discusses how agency leaders should be encouraged to improve regulatory science, include a patient’s…

Real-World Studies Show Insufficiency For Informing Clinical, Reimbursement Decisions of Novel Cancer Drugs

Cancer Network, 31 Aug 2021

“This retrospective cohort study provides the first systematic evaluation of RWD [real-world] studies reporting the…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.